Hosted by Jan Majta · 🇺🇸 US · EN · 39 episodes
Established thought leaders with verified media credentials.
A fast paced, AI-generated podcast on pharma and biotech news.
Jan Majta hosts Pharma Digest, a science show with 39 episodes published.
Lilly pays $6.3B upfront for sleep disorder-focused Centessa in latest neuroscience playAmbrosia scores $100M series B to take next-gen oral GLP-1 into the clinicMerck enlists antibody hunter Infinimmune for $838M biobuc
Show notes
Mapping the Trillion-Gene Universe: The Startup That Wants to Teach AI the Language of LifeWhy Data Infrastructure Determines AI Success in Drug DiscoveryPhenoTips, Health Institutions Launch C$5.4M AI Genomic Medicine I
Show notes
AstraZeneca delivers dream result as phase 3 COPD hits breathe life into class rocked by flops Lilly further embraces Insilico’s AI tech, inking R&D collab worth up to $2.75B Merck dives into detailed phase 3 data showin
Show notes
The Value of Prediction, and Cost of Success, in Drug HuntingMerck hands over $20M in IBD drug target deal with Flagship's QuotientThe N-of-1 Revolution in Personalized Medicine
Show notes
- Merck, girding for Keytruda cliff, flies toward promising CML asset with $6.7B Terns acquisition - OrbiMed-backed Pinnacle adds $89M series B to power oral peptide pipeline - Sarepta's big bet on Arrowhead's siRNA asse
Show notes
Baylor College of Medicine Taps Nautilus’ Voyager for Cancer ProteomicsThe Download: OpenAI is building a fully automated researcher, and a psychedelic trial blind spotFrom scientist to bioinformatician: how AI coding to
Show notes
Lilly's triple-G bet lowers blood sugar, prompts 16.8% weight loss in phase 3 diabetes trialSTAT+: A biotech turns to Apple Watch to study its Parkinson’s drugWhich FDA Division Has the Most Stability As AI Tools Get Ado
Show notes
With its first AI model release, Xaira tests scaling laws in virtual cellsNVIDIA GTC 2026: Agentic AI Inflection Hits Healthcare and Life SciencesDOE Announces $293M Funding Opportunity as Genesis Mission Moves Towa
Show notes
Pfizer's hotly tipped breast cancer prospect delivers phase 2 winAspen's 1-year data for Parkinson's cell therapy plant seeds for phase 3 trialCrossbow hits $77M series B round to bankroll quiver of T-Bolts
Show notes
Roche inks Nvidia deal to bolster AI factory, speed drug and diagnostic developmentWhy most labs are not ready for AI: Cenevo shares what must changeFrench AI Startup Building World Models Raises $1.03 billion
Show notes
Structure touts 16% weight loss for aleniglipron as 'highest efficacy' for an oral GLP-1 yetR1 zooms out of stealth with $77.5M series A to advance chronic kidney disease treatmentDanish biotech Gubra plots Roivant-like
Show notes
Stop asking for an AI strategy: 3 questions clinical leaders should ask insteadThe Real Test for AI Diagnostics Isn’t Performance — It’s Clinical AdoptionReal-World Evidence Meets Machine Learning: What It Takes to Futur
Show notes
CytomX surges on positive data for ‘masked’ ADC in colorectal cancerAstellas walks away from $1.6B biobucks T-cell engager pact with CytomX after 6 yearsJAMA Neurology Publishes Results from PARADIGM Phase 2b Trial of Pr
Show notes
Startup Waiv Spins Out of Owkin With $33M to Bring AI Precision to Cancer Decisions Artificial Intelligence and the Data Quality Problem No One Can Ignore Microsoft Enters Healthcare Chatbot Race with Copilot Health
Show notes
GSK’s RSV vaccine wins broader FDA clearanceBimzelx tops Skyrizi in head-to-head psoriatic arthritis trialWith FDA go ahead, a China biotech notches a first in cell therapy testing
Show notes
An AI Driven Approach to Address the Non-Responder Gap in Radiopharmaceutical TherapyAgentic AI Swarms Degrade Decision-MakingSTAT+: AI agents are rapidly spreading in health care, but validation is lacking
Show notes
Ultragenyx gene therapy hits co-primary endpoint in phase 3 rare disease study, teeing up potential winBridgeBio's muscle weakness data impress ahead of FDA filingFledgling French biotech pens $128M deal for Kezar's prec
Show notes
STAT+: New nonprofit launches with at least $500 million to modernize scientific process for AI eraBota/Enhe’s SAION AI push toward closed‑loop, machine‑protocol‑driven biomanufacturingTailored Training Can Address Bioph
Show notes
Regeneron's obesity drug shows Zepbound-like efficacy in phase 3Tenacia builds $308M biobucks deal with Rapport to develop epilepsy drug in greater China$270M RNA Drug Spinout Targets Rare Genetic Cardiomyopathies
Show notes
Smarter Filings, Smarter FactoriesHealth AI startup to benefit from $1 billion funding round for Yann LeCun’s AMIBreakout Ventures launches $114M AI-focused fund
Show notesSponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchShows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
To pitch Pharma Digest, visit https://podcasters.spotify.com/pod/show/jan-majta2 for contact information, then craft a tight one-paragraph hook that ties your expertise to a gap in their recent science coverage.
Pharma Digest is hosted by Jan Majta. The show is categorised under science (life) and has published 39 episodes.
Pharma Digest has published 39 episodes.
Pharma Digest regularly covers science, life. It sits in the science category, with a life focus.
Pharma Digest is accessible for guests with genuine science expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
Pharma Digest hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of Pharma Digest average 13 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates Pharma Digest's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 8 days ago.
